Tissue Regenix Group plc (AIM:TRX)

Tissue Regenix Group Revenue

Tissue Regenix Group had revenue of $13.80M USD in the half year ending June 30, 2025, a decrease of -2.14%. This brings the company's revenue in the last twelve months to $27.75M, up 4.29% year-over-year. In the year 2024, Tissue Regenix Group had annual revenue of $28.65M with 8.85% growth.

• Revenue (ttm): $27.75M
• Revenue Growth: +4.29%
• P/S Ratio: 0.25
• Revenue / Employee: $301.66K
• Employees: 92
• Market Cap: 5.16M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.65M	2.33M	8.85%
Dec 31, 2023	26.32M	1.84M	7.52%
Dec 31, 2022	24.48M	4.73M	23.95%
Dec 31, 2021	19.75M	3.27M	19.87%
Dec 31, 2020	16.47M	-788.11K	-4.57%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jan 2, 2026

Data Sources Report a data error